Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Steiger

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Clinical Neuropharmacology|December 1, 1992
The clinical efficacy of single morning doses of levodopa methyl ester: dispersible Madopar and Sinemet plus in Parkinson diseaseM J Steiger, F Stocchi, L Bramante, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 17, 1998
Hyperekplexia and trismus due to brainstem encephalopathyM W Kellett, P R Humphrey, B M Tedman, et al.
Annals of Neurology|April 1, 1993
Successful outcome of progressive multifocal leukoencephalopathy with cytarabine and interferonM J Steiger, G Tarnesby, S Gabe, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1992
Hemiballism and chorea in a patient with parkinsonism due to a multisystem degenerationM J Steiger, M Pires, F Scaravilli, et al.
Lancet (London, England)|October 22, 1988
Cyclosporin toxicity and colitisA Innes, P A Rowe, M C Foster, et al.
Journal of Neurology|January 1, 1996
Double-blind study of the activity and tolerability of cabergoline versus placebo in parkinsonians with motor fluctuationsM J Steiger, T El-Debas, T Anderson, et al.
Acta Neurologica Scandinavica|August 1, 1992
Debrisoquine hydroxylation in Parkinson's diseaseM J Steiger, P Lledo, N P Quinn, et al.
Clinical Neuropharmacology|June 1, 1991
The clinical efficacy of oral levodopa methyl ester solution in reversing afternoon "off" periods in Parkinson's diseaseM J Steiger, F Stocchi, A Carta, et al.
Clinical Neuropharmacology|June 1, 1994
Plasma HVA levels following debrisoquine administration do not reflect cerebral dopamine loss in early Parkinson's diseaseS Rose, J G Hindmarsh, M J Steiger, et al.
Journal of the Royal Society of Medicine|September 1, 1992
Botulinum toxin treatment of spasmodic torticollisT J Anderson, J Rivest, R Stell, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Clinical Neuropharmacology|December 1, 1992
The clinical efficacy of single morning doses of levodopa methyl ester: dispersible Madopar and Sinemet plus in Parkinson diseaseM J Steiger, F Stocchi, L Bramante, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 17, 1998
Hyperekplexia and trismus due to brainstem encephalopathyM W Kellett, P R Humphrey, B M Tedman, et al.
Annals of Neurology|April 1, 1993
Successful outcome of progressive multifocal leukoencephalopathy with cytarabine and interferonM J Steiger, G Tarnesby, S Gabe, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1992
Hemiballism and chorea in a patient with parkinsonism due to a multisystem degenerationM J Steiger, M Pires, F Scaravilli, et al.
Lancet (London, England)|October 22, 1988
Cyclosporin toxicity and colitisA Innes, P A Rowe, M C Foster, et al.
Journal of Neurology|January 1, 1996
Double-blind study of the activity and tolerability of cabergoline versus placebo in parkinsonians with motor fluctuationsM J Steiger, T El-Debas, T Anderson, et al.
Acta Neurologica Scandinavica|August 1, 1992
Debrisoquine hydroxylation in Parkinson's diseaseM J Steiger, P Lledo, N P Quinn, et al.
Clinical Neuropharmacology|June 1, 1991
The clinical efficacy of oral levodopa methyl ester solution in reversing afternoon "off" periods in Parkinson's diseaseM J Steiger, F Stocchi, A Carta, et al.
Clinical Neuropharmacology|June 1, 1994
Plasma HVA levels following debrisoquine administration do not reflect cerebral dopamine loss in early Parkinson's diseaseS Rose, J G Hindmarsh, M J Steiger, et al.
Journal of the Royal Society of Medicine|September 1, 1992
Botulinum toxin treatment of spasmodic torticollisT J Anderson, J Rivest, R Stell, et al.
Pageof 4